SSG
ALKS icon

Summit Securities Group’s Alkermes ALKS Stock Holding History

Summit Securities Group’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-323
Closed -$9K – 614
2024
Q3 		$9K Buy
+323
New +$8.61K ﹤0.01% 382

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Summit Securities Group's ALKS Position: Q4 2024 in Review

Summit Securities Group sold out of Alkermes (ALKS) in Q4 2024, closing a stake of 323 shares — an estimated $9K sold.

Summit Securities Group first reported a position in ALKS in Q3 2024 and held it in 1 quarter. The position peaked at $9K in Q3 2024. 343 funds tracked by Wall St. Rank hold ALKS as of Q4 2024.

  • Summit Securities Group reported no remaining Alkermes position as of Q4 2024 after selling out during the quarter.
  • Summit Securities Group sold 323 Alkermes shares in Q4 2024, an estimated $9K.
  • Summit Securities Group first reported a position in Alkermes in Q3 2024 and held it in 1 quarter.
  • Summit Securities Group's Alkermes position peaked at $9K in Q3 2024.
  • 343 funds tracked by Wall St. Rank held Alkermes as of Q4 2024.

Based on Summit Securities Group's 13F filing for Q4 2024, filed 12 Feb 2025.